Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

111, Inc.

YINASDAQ
Healthcare
Medical - Pharmaceuticals
$8.38
$0.18(2.15%)
U.S. Market is Open • 14:29

111, Inc. Fundamental Analysis

111, Inc. (YI) shows moderate financial fundamentals with a PE ratio of -7.06, profit margin of -0.52%, and ROE of 10.54%. The company generates $13.5B in annual revenue with weak year-over-year growth of -3.66%.

Key Strengths

Cash Position692.74%
PEG Ratio-0.18

Areas of Concern

Operating Margin-0.07%
We analyze YI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 49.9/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
49.9/100

We analyze YI's fundamental strength across five key dimensions:

Efficiency Score

Weak

YI struggles to generate sufficient returns from assets.

ROA > 10%
-2.82%

Valuation Score

Excellent

YI trades at attractive valuation levels.

PE < 25
-7.06
PEG Ratio < 2
-0.18

Growth Score

Moderate

YI shows steady but slowing expansion.

Revenue Growth > 5%
-3.66%
EPS Growth > 10%
83.86%

Financial Health Score

Excellent

YI maintains a strong and stable balance sheet.

Debt/Equity < 1
-0.30
Current Ratio > 1
1.07

Profitability Score

Weak

YI struggles to sustain strong margins.

ROE > 15%
10.54%
Net Margin ≥ 15%
-0.52%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is YI Expensive or Cheap?

P/E Ratio

YI trades at -7.06 times earnings. This suggests potential undervaluation.

-7.06

PEG Ratio

When adjusting for growth, YI's PEG of -0.18 indicates potential undervaluation.

-0.18

Price to Book

The market values 111, Inc. at -0.72 times its book value. This may indicate undervaluation.

-0.72

EV/EBITDA

Enterprise value stands at 213.17 times EBITDA. This signals the market has high growth expectations.

213.17

How Well Does YI Make Money?

Net Profit Margin

For every $100 in sales, 111, Inc. keeps $-0.52 as profit after all expenses.

-0.52%

Operating Margin

Core operations generate -0.07 in profit for every $100 in revenue, before interest and taxes.

-0.07%

ROE

Management delivers $10.54 in profit for every $100 of shareholder equity.

10.54%

ROA

111, Inc. generates $-2.82 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.82%

Following the Money - Real Cash Generation

Operating Cash Flow

111, Inc. generates limited operating cash flow of $111.95M, signaling weaker underlying cash strength.

$111.95M

Free Cash Flow

111, Inc. generates weak or negative free cash flow of $96.82M, restricting financial flexibility.

$96.82M

FCF Per Share

Each share generates $11.17 in free cash annually.

$11.17

FCF Yield

YI converts 19.87% of its market value into free cash.

19.87%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-7.06

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.18

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.72

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.04

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.30

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.07

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.11

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

-0.04

vs 25 benchmark

How YI Stacks Against Its Sector Peers

MetricYI ValueSector AveragePerformance
P/E Ratio-7.0629.43 Better (Cheaper)
ROE10.54%800.00% Weak
Net Margin-0.52%-20145.00% (disorted) Weak
Debt/Equity-0.300.30 Strong (Low Leverage)
Current Ratio1.074.64 Neutral
ROA-2.82%-17936.00% (disorted) Weak

YI outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews 111, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

246.05%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

87.75%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

148.96%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ